Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
Leading Supply Chain & Logistics Solution Utilizing Continuous Delivery Experience (CDX)
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite.
Fetchr is an international express, mail delivery and logistics services company.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
CoEdition is a retail company that specializes in the fashion marketplace dedicated to women.
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
Noonlight combines advanced technology (APIs) with real humans to protect and comfort people so they can live freely.
Flow is a platform that enables e-commerce companies to go global.
Frontier Car Group develops, launches, and operates used-automotive marketplaces within emerging market economies.
The Yes is a next generation AI-powered shopping platform.
Jyve is a tech platform that matches brands’ in-store execution needs with the right skilled labor, at the right time.
Stockwell is combining the convenience of online ordering with the instant gratification of real world retail.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
Drive.ai creates AI software for autonomous vehicles.
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Holloway publishes comprehensive practical Guides, each researched, written, and refined by experts.
Enigma provides reliable data and insights on the identity, activity, and risk profile of every small business.
Uptake Technologies designs and develops enterprise software.
Igneous offers an unstructured data management solution giving data-centric enterprises visibility, protection, and data mobility at scale.
New Enterprise Associates has invested in 641 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Biotechnology, Medical, Health Care, Internet, Software. The firm invests across 56 different industry categories.
Among tracked funding rounds, Frontier Car Group received $400.0M in a Series D round. New Enterprise Associates's total known invested capital is $35.5B.
New Enterprise Associates's average investment size is $69.0M across its portfolio of 641 companies.
Recent New Enterprise Associates portfolio additions include POLYNEURON, ClearMetal, Upskill, Fetchr, Aurinia Pharmaceuticals. These companies were founded in 2020 or later.